SCHEMBL29482107

SCHEMBL29482107

CCCCCC1=C(C=O)CCC(C)(C)C1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SCD O00767 1/20 0.33
HIF1A Q16665 1/20 0.31
EPAS1 Q99814 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29482108 1.00 SCD (0.33) SCDHIF1AEPAS1
SCHEMBL29482102 0.87 SCD (0.33) SCDHIF1AEPAS1
SCHEMBL9446255 0.74 SCD (0.38) SCDHIF1AEPAS1
SCHEMBL28102844 0.73 SCD (0.41) SCDHIF1AEPAS1
SCHEMBL28084243 0.73 SCD (0.41) SCDHIF1AEPAS1
SCHEMBL22597604 0.72
SCHEMBL29482096 0.71 TSHR (0.31) SCD
SCHEMBL22597621 0.71
SCHEMBL22597620 0.71
SCHEMBL29482098 0.68 TSHR (0.31) SCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111801327-B Benzamide compounds 里科瑞尔姆IP控股有限责任公司 2024-02-09 CN disclosed
CN-115461335-A BCL-2 protein inhibitors 里科瑞尔姆IP控股有限责任公司 2022-12-09 CN disclosed
CN-114126616-A Nanoparticle formulations of BCL-2 inhibitors 里科瑞尔姆IP控股有限责任公司 2022-03-01 CN disclosed